种族影响新型冠状病毒肺炎住院患者深静脉血栓、肺栓塞和急性肾损伤的不良结局
本研究回顾性分析了2020年3月11日至2021年5月27日连续住院的876例新型冠状病毒肺炎患者,探讨深静脉血栓/肺栓塞和急性肾损伤的种族差异。黑种人/非洲裔美国患者深静脉血栓/肺栓塞发生率最高(16.2%),急性肾损伤比例也更高;黑种人/非洲裔美国种族和D-二聚体水平是深静脉血栓/肺栓塞的独立预测因素。
要点
- 黑种人/非洲裔美国患者深静脉血栓/肺栓塞发生率为16.2%,高于白种人患者的7.5%(P=0.03)。
- 黑种人/非洲裔美国种族(OR 2.0)和较高D-二聚体水平(OR 1.1)是深静脉血栓/肺栓塞的独立预测因素。
- 黑种人/非洲裔美国种族(OR 2.3)、较低血红蛋白(OR 0.84)、男性(OR 1.7)、高血压(OR 2.1)和年龄(OR 1.02)是急性肾损伤的预测因素。
核心结论
- 在这项单中心病例系列中,黑种人/非洲裔美国新型冠状病毒肺炎患者深静脉血栓/肺栓塞和急性肾损伤的发生率更高。
- 黑种人/非洲裔美国种族和D-二聚体水平是深静脉血栓/肺栓塞的独立预测因素;黑种人/非洲裔美国种族、血红蛋白和D-二聚体水平是急性肾损伤的独立预测因素。
研究设计与样本
- 回顾性分析2020年3月11日至2021年5月27日连续住院的新型冠状病毒肺炎患者的前瞻性收集数据,共纳入876例。
- 主要结局指标为深静脉血栓/肺栓塞发生率和死亡率;次要结局指标包括住院时间、重症监护需求、再入院和急性肾损伤的差异。
- 采用多变量回归模型评估主要和次要结局指标的独立预测因素。
主要发现
- 876例患者平均年龄64.4±16.2岁,女性355例(40.5%);白种人694例(79.2%),黑种人/非洲裔美国人111例(12.7%),亚洲人48例(5.5%),其他23例(2.6%)。
- 深静脉血栓/肺栓塞总体发生率为8.7%;黑种人/非洲裔美国患者为16.2%(n=18),亚洲患者为10.4%(n=5),白种人患者为7.5%(n=52),其他为4.4%(n=1),组间差异P=0.03。
- 除急性肾损伤外,其他住院结局按种族比较均无差异:住院时间P=0.33,重症监护需求P=0.20,再入院率P=0.52,院内全因死亡率P=0.29。
- 急性肾损伤发生率在不同种族间存在差异,黑种人/非洲裔美国患者比例更高(P=0.003)。
- 多变量回归分析显示,黑种人/非洲裔美国种族(OR 2.0;95%CI 1.0-4.0;P=0.04)和较高D-二聚体水平(OR 1.1;95%CI 1.1-1.2;P<0.0001)是深静脉血栓/肺栓塞的预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of the present study was to explore the racial disparities in the incidence of deep vein thrombosis (DVT), pulmonary embolism (PE), and acute kidney injury (AKI) in hospitalized patients with coronavirus disease 2019 (COVID-19). METHODS: A retrospective analysis was performed of prospectively collected data of consecutive COVID-19 patients hospitalized from March 11, 2020 to May 27, 2021. The primary outcome measures were the incidence of DVT/PE and mortality. The secondary outcome measures included differences in the length of hospitalization, need for intensive care unit care, readmission, and AKI. Multivariable regression models were used to assess for independent predictors of the primary and secondary outcome measures. RESULTS: The present study included 876 hospitalized patients with COVID-19. The mean age was 64.4 ± 16.2 years, and 355 were women (40.5%). Of the 876 patients, 694 (79.2%) had identified as White, 111 (12.7%) as Black/African American, 48 (5.5%) as Asian, and 23 (2.6%) as other. The overall incidence of DVT/PE was 8.7%. The DVT/PE incidence rates differed across the race groups and was highest for Black/African American patients (n = 18; 16.2%), followed by Asian patients (n = 5; 10.4%), White patients (n = 52; 7.5%), and other (n = 1; 4.4%; P = .03). All but one of the hospitalization outcomes examined demonstrated no differences according to race, including the hospitalization stay (P = .33), need for intensive care unit care (P = .20), readmission rates (P = .52), and hospital all-cause mortality (P = .29). The AKI incidence differed among races, affecting a higher proportion of Black/African American patients (P=.003). On multivariable regression analysis, Black/African American race (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.0-4.0; P = .04) and higher D-dimer levels (OR, 1.1; 95% CI, 1.1-1.2; P < .0001) were predictors of DVT/PE. In addition, Black/African American race (OR, 2.3; 95% CI, 1.4-3.7; P = .001), lower hemoglobin levels (OR, 0.84; 95% CI, 0.8-0.9; P ≤ .0001), male sex (OR, 1.7; 95% CI, 1.2-2.4; P = .005), hypertension (OR, 2.1; 95% CI, 1.4-3.1; P = .0005), and older age (OR, 1.02; 95% CI, 1.006-1.03; P = .003) were predictors of AKI. CONCLUSIONS: In our single-center case series, we found a higher incidence of DVT/PE and AKI among Black/African American patients with COVID-19. Black/African American race and D-dimer levels were independent predictors of DVT/PE, and Black/African American race, hemoglobin, and D-dimer levels were independent predictors of AKI.
引用
- Erben Y, Marquez CP, Prudencio M, et al. Race affects adverse outcomes of deep vein thrombosis, pulmonary embolism, and acute kidney injury in coronavirus disease 2019 hospitalized patients. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 36100130. doi:10.1016/j.jvsv.2022.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。